Sort
130,381 grants matching “hiv”
Project 2: Interrogating immuno-metabolic programs using a novel Flow Cytometry based assay to reveal novel T cell subsets in SARS-CoV-2 infected patients
$983,246Jonathan D Powell · Johns Hopkins University · U54 · FY2020 · CA
HIV Prevention Maintenance for African American Teens Continuation
$983,159Ralph J Diclemente · Emory University · R01 · FY2008 · MH
Coronavirus neutralizing antibody epitopes and immunogens
$983,100Paul D Bieniasz · Rockefeller University · P01 · FY2023 · AI
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responses
$983,100Michel C Nussenzweig · Rockefeller University · P01 · FY2023 · AI
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$983,087Mary N. Carrington · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Conserved Elements Therapeutic DNA Vaccine for HIV
$983,076Deborah L. Fuller · University Of Washington · R01 · FY2016 · AI
Conserved Elements Therapeutic DNA Vaccine for HIV
$983,076Deborah L. Fuller · University Of Washington · R01 · FY2014 · AI
Conserved Elements Therapeutic DNA Vaccine for HIV
$983,075Deborah L. Fuller · University Of Washington · R01 · FY2015 · AI
Project 3
$983,033Alexander Marson · University Of California, San Francisco · U54 · FY2023 · AI
Health Promotion and Disease Prevention Research Center
$983,000Tabia Henry-Akintobi · Morehouse School Of Medicine · U48 · FY2015 · DP
Thermo Electron LTQ Orbitrap XL ETD with ESI and Dionex Ultimate 3000 HPLC System
$982,989Mark R Chance · Case Western Reserve University · S10 · FY2010 · RR
Activated Sugars, Oligosaccharides and Glycans for Antiviral Research
$982,971Leila Aminova · Midwest Bioprocessing Center, Llc · R44 · FY2021 · GM
Prevention with Positives Intervention at HIV Clinics
$982,958National Institute Of Mental Health · Y01 · FY2015 · MH
Reaching for the end of pediatric AIDS: Modeling strategies to strengthen the maternal-child HIV care continuum and eliminate vertical HIV transmission.
$982,937Andrea Lynne Ciaranello · Massachusetts General Hospital · R37 · FY2025 · HD
Rapid sensitive low-cost test for resistant microbes causing hospital infections
$982,928Sadanand Gite · First Light Diagnostics , Inc. · R44 · FY2011 · AI
Pre-Phase I Evaluations
$982,834Craig Walter Hendrix · Imquest Biosciences · U19 · FY2013 · AI
India International Center for Excellence in Research
$982,538Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
$982,311David A Williams · Boston Children'S Hospital · U01 · FY2020 · AI
Preclinical development of PPCM vaginal contraceptive to submit IND.
$982,217Mary B Weitzel · Yaso Therapeutics Inc · R44 · FY2018 · HD
Pathogenesis Studies Of Simian Immunodeficiency Virus Infection Of Monkeys
$982,177Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Vaccine Studies of Simian Immunodeficiency Virus (SIV) in Macaques
$982,177Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Boston Pediatric AIDS Clinical Trials Unit
$981,946Children'S Hospital Boston · U01 · FY2004 · AI
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine
$981,917Amit Praful Khandhar · Hdt Bio Corporation · R33 · FY2024 · AI
Novel spectinamide antibiotics for the treatment of MDR/XDR tuberculosis
$981,833Michelle M. Butler · Microbiotix, Inc · R44 · FY2016 · AI
Commercialization of PANDAA qDx for rapid drug resistance genotyping of protease inhibitor ART failures in resource-limited settings.
$981,812Iain James Macleod · Aldatu Biosciences, Inc. · SB1 · FY2023 · AI